Dr. Grosso will develop and implement the company’s expanding clinical trial agenda. Tevogen’s cell therapy research pipeline focuses on virology, neurology, and oncology. Tevogen is reported as the ...
DANBURY, Conn.--(BUSINESS WIRE)--Perosphere Technologies (Perosphere Technologies Inc.), a private medical technologies company focused on developing next-generation coagulation diagnostics, today ...
Columbia, Md.-based The Center for Advanced Orthopaedics’ Nicholas Grosso, MD, urged consumers to seek out private practices in a column for U.S. News & World Report. 1. Although the quantity of ...
Dr. Nicholas Grosso: Extending the maximum stay time at ASCs to 48 hours would make outpatient surgery a safer option for a wider variety of patients, like those who may be at-risk for surgical ...
In this episode, Dr. Nicholas Grosso and Dr. Louis Levitt, Co-Founders of The Centers for Advanced Orthopaedics and MedVanta, discuss their physician-led MSO and how it is transforming musculoskeletal ...
Anthony Grosso has been appointed to the role of head of scientific affairs at Accord Healthcare Europe. Dr Grosso will be responsible for overseeing Accord’s strategy for sustained patient access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results